-
12441por Tomasello, Elena, Pollet, Emeline, Vu Manh, Thien-Phong, Uzé, Gilles, Dalod, Marc“…Emphasis will be put on the potentially deleterious functions of IFN-I in human immunodeficiency virus type 1 (HIV-1) infection, and on the respective roles of IFN-I and IFN-III in promoting resolution of hepatitis C virus (HCV) infection. We will then discuss how the balance between beneficial versus deleterious IFN-I responses is modulated by several key parameters including (i) the subtypes and dose of IFN-I produced, (ii) the cell types affected by IFN-I, and (iii) the source and timing of IFN-I production. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12442por Christiansen, Karen M., Mössner, Belinda K., Hansen, Janne F., Jarnbjer, Erik F., Pedersen, Court, Christensen, Peer B.“…The study included 845 patients: 597 (71%) with hepatitis C virus (HCV), 235 (28%) with hepatitis B virus (HBV) and 13 (2%) with dual infection. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12443por Hayashi, Kanna, Milloy, Michael-John, Wood, Evan, Dong, Huiru, Montaner, Julio SG, Kerr, Thomas“…INTRODUCTION: While HIV/AIDS remains an important cause of death among people who inject drugs (PWID), the potential mortality burden attributable to hepatitis C virus (HCV) infection among this population is of increasing concern. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12444por Stinton, Laura M., Bentow, Chelsea, Mahler, Michael, Norman, Gary L., Eksteen, Bertus, Mason, Andrew L., Kaplan, Gilaad G., Lindkvist, Bjorn, Hirschfield, Gideon M., Milkiewicz, Piotr, Cheung, Angela, Janssen, Harry L. A., Fritzler, Marvin J.“…METHODS: A total of 244 PSC and 254 control [autoimmune hepatitis (AIH), primary biliary cirrhosis (PBC), hepatitis C viral infection (HCV), hepatitis B viral infection (HBV), and healthy controls] sera and their clinical correlations were retrospectively analyzed for PR3-ANCA determined by ELISA and a new chemiluminescence immunoassay (CIA). …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12445“…Laboratory investigations (complete blood counts, renal and liver function tests, serum parathormone levels, serum electrolytes, alkaline phosphatase, random blood sugar, and Hepatitis C virus (HCV) antibodies) were evaluated. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12446por Lafaurie, Matthieu, De Sousa, Barbara, Ponscarme, Diane, Lapidus, Nathanael, Daudon, Michel, Weiss, Laurence, Rioux, Christophe, Fourn, Erwan, Katlama, Christine, Molina, Jean-Michel“…In univariate analysis, chronic hepatitis C, a history of urolithiasis, prior use of indinavir, ATV duration, undetectable plasma HIV RNA, use of ritonavir as a booster and serum free bilirubin level were associated with ATV-urolithiasis. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12447por Johnson, Mark, Borland, Julie, Chen, Shuguang, Savina, Paul, Wynne, Brian, Piscitelli, Stephen“…AIMS: The aim was to evaluate the effect of boceprevir and telaprevir on dolutegravir pharmacokinetics (PK); the effect of dolutegravir on boceprevir and telaprevir PK was assessed through comparison with historical data for each hepatitis C virus (HCV) drug's prescribing information alone. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12448por Nacif, Lucas Souto, David, André Ibrahim, Pinheiro, Rafael Soares, Diniz, Marcio Augusto, Andraus, Wellington, Junior, Ruy Jorge Cruz, Carneiro D′Albuquerque, Luiz A“…RESULTS: The most frequent indication for liver transplantation was hepatitis C cirrhosis (47.7%), with a higher prevalence observed in male patients (68.18%). …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12449por Shiozawa, Kazue, Watanabe, Manabu, Ikehara, Takashi, Ogino, Yu, Umakoshi, Tomoko, Matsukiyo, Yasushi, Kogame, Michio, Matsui, Teppei, Kikuchi, Yoshinori, Igarashi, Yoshinori, Sumino, Yasukiyo“…An 81-year-old male with hepatitis C virus-related cirrhosis was diagnosed with a HCC of 35 mm in diameter in S5 detected by dynamic computed tomography (CT) and contrast-enhanced ultrasonography (CEUS). …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12450“…Local production of BAFF in granulomatous lesions and elevated levels of serum BAFF in AAV provide a rationale for BAFF-targeted therapies not only in AAV but also in other forms of vasculitis such as Behcet’s disease, large-vessel vasculitis, or cryoglobulinemic vasculitis secondary to chronic hepatitis C infection. BAFF-targeted therapies have a very solid safety profile, and may have an additional benefit of preferentially targeting newly arising autoreactive B cells over non-self-reactive B cells.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12451por Peveling-Oberhag, Jan, Seiz, Anna, Döring, Claudia, Hartmann, Sylvia, Köberle, Verena, Liese, Juliane, Zeuzem, Stefan, Hansmann, Martin-Leo, Piiper, Albrecht“…Tissue from surgically resected hepatitis C–associated HCC from six well-matched patients was microdissected using laser microdissection and pressure catapulting technique. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12452“…We contrast this to the mechanism employed by the distantly related hepacivirus hepatitis C virus, in which STING is bound and inactivated by the NS4B protein. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12453“…Of the 216 patients, 0.46% was carrier of hepatitis C virus, 30.1% had primary SS (pSS), and 8.8% had secondary SS (sSS). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12454“…On the other hand, there are distinct advantages of targeting the host, such as creating a high barrier to resistance, providing broad coverage of different genotypes/serotypes and possibly even multiple viruses, and expanding the list of potential targets, when druggable viral targets are limited. Taking hepatitis C virus (HCV) as the example, there are more than 20 inhibitors of the viral protease, polymerase and NS5A protein currently in advanced clinical testing. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12455por Tiwari, Aseem K., Pandey, Prashant K., Dara, Ravi C., Rawat, Ganesh S., Raina, Vimarsh, Bhargava, Richa“…STS with good sensitivity and specificity helps enhance blood safety and consolidation of STS along with other transfusion transmittable infections such as human immunodeficiency virus, hepatitis-C virus, and hepatitis-B virus helps in reducing the errors and enhances efficiency. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12456por Whiteside, Y. Omar, Selik, Richard, An, Qian, Huang, Taoying, Karch, Debra, Hernandez, Angela L, Hall, H. Irene“…RESULTS : Overall, compared with the general population, persons diagnosed with HIV infection had higher age-adjusted rates of death reported with hepatitis B (rate ratio [RR]=42.6; 95% CI: 34.7-50.7), hepatitis C (RR=19.4; 95% CI: 18.1-20.8), liver disease excluding hepatitis B or C (RR=2.1; 95% CI: 1.8-2.3), kidney disease (RR=2.4; 95% CI: 2.2-2.6), and cardiomyopathy (RR=1.9; 95% CI: 1.6-2.3), but lower rates of death reported with ischemic heart disease (RR=0.6; 95% CI: 0.6-0.7) and heart failure (RR=0.8; 95% CI: 0.6-0.9). …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12457por Ulu, Mehmet, Alacacioglu, Ahmet, Yuksel, Esma, Pamukk, Baris O., Bozkaya, Giray, Ari, Alpay, Yuksel, Arif, Sop, Gulten, Alacacioglu, Inci“…When we evaluated galectin-3 levels in HCC patients, it was found to be 3.92 ng/mL in HCC secondary to hepatitis B and 5.37 ng/mL in HCC secondary to hepatitis C. CONCLUSION: Serum galectin-3 levels in patients with chronic HBV or HCV may guide us about progression to cirrhosis or HCC and prognosis of the disease. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12458“…Inclusion criteria are hemodialysis patients who received the HB vaccine and patients with concomitant hepatitis C. Exclusion criteria are patients who refused the vaccine and patients who did not complete the vaccine course. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12459por Isken, Olaf, Langerwisch, Ulrike, Jirasko, Vlastimil, Rehders, Dirk, Redecke, Lars, Ramanathan, Harish, Lindenbach, Brett D., Bartenschlager, Ralf, Tautz, Norbert“…Hepatitis C virus (HCV) infection is a leading cause of liver disease worldwide. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12460“…Beyond these risks, the Ukrainian conflict could also negatively impact control of other infectious diseases that are converging with HIV and injection drug use, such as multidrug-resistant tuberculosis and hepatitis C virus. The continuing conflict is also likely to have a significant negative impact on Ukraine’s fragile public health system leading to even worse population health outcomes than currently experienced by the country. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto